Literature DB >> 6462114

Endocrine complications of topical and intralesional corticosteroid therapy.

J A Curtis, E Cormode, B Laski, J Toole, N Howard.   

Abstract

Four previously healthy children acquired skin problems that were treated with topical or intralesional fluorinated corticosteroids. Three developed signs that suggested Cushing's syndrome 1-4 months after initial treatment. Investigation showed low plasma cortisol levels and inadequate response to corticotrophin stimulation. After 7 months of treatment with topical steroids the fourth child presented with failure to thrive; during a febrile illness he had a convulsion followed by acute hypotension which responded to parenteral corticosteroid administration. Adrenal function was not studied in this patient. Although fluorinated corticosteroids seldom lead to overt adrenal suppression in children, they may impair pituitary-adrenal responses in some. Such patients should be given oral or parenteral steroid cover in the event of illness or trauma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6462114      PMCID: PMC1627608          DOI: 10.1136/adc.57.3.204

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  Hypertrophic scars and keloids. A collective review.

Authors:  L D Ketchum; I K Cohen; F W Masters
Journal:  Plast Reconstr Surg       Date:  1974-02       Impact factor: 4.730

2.  A case of growth retardation and cushing's syndrome due to excessive application of betamethasone-17-valerate ointment.

Authors:  B J Vermeer; G F Heremans
Journal:  Dermatologica       Date:  1974

3.  Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate.

Authors:  J A Keipert; R Kelly
Journal:  Med J Aust       Date:  1971-03-06       Impact factor: 7.738

4.  Wasting of napkin area after repeated use of fluorinated steroid ointment.

Authors:  A M Johns; B D Bower
Journal:  Br Med J       Date:  1970-02-07

5.  Percutaneous absorption of corticosteroids: systemic effects.

Authors:  R B Scoggins; B Kliman
Journal:  N Engl J Med       Date:  1965-10-14       Impact factor: 91.245

6.  Follow-up on treatment of hypertrophic scars and keloids with triamcinolone.

Authors:  L D Ketchum; D W Robinson; F W Masters
Journal:  Plast Reconstr Surg       Date:  1971-09       Impact factor: 4.730

7.  Regional variation in percutaneous penetration of 14C cortisol in man.

Authors:  R J Feldmann; H I Maibach
Journal:  J Invest Dermatol       Date:  1967-02       Impact factor: 8.551

8.  Percutaneous absorption of hydrocortisone in children.

Authors:  B I Feinblatt; T Aceto; G Beckhorn; E Bruck
Journal:  Am J Dis Child       Date:  1966-09

9.  The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.

Authors:  D D Munro
Journal:  Br J Dermatol       Date:  1976-03       Impact factor: 9.302

10.  Effect of potent topical steroids on plasma-cortisol levels of infants and children with eczema.

Authors:  M Feiwel; V H James; E S Barnett
Journal:  Lancet       Date:  1969-03-08       Impact factor: 79.321

View more
  4 in total

Review 1.  Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.

Authors:  Therdpong Tempark; Voraluk Phatarakijnirund; Susheera Chatproedprai; Suttipong Watcharasindhu; Vichit Supornsilchai; Siriwan Wananukul
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

3.  A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid.

Authors:  Norazirah Md Nor; Rasimah Ismail; Adawiyah Jamil; Shamsul Azhar Shah; Farah Hani Imran
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

4.  IL-4 and interferon-gamma production in children with atopic disease.

Authors:  M Tang; A Kemp; G Varigos
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.